Longboard Pharmaceuticals

Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for neurological diseases.

graphic of the brain and the electrical signals that make it up
Biotech

Lundbeck signs $2.5B check for Longboard and its epilepsy med

After spying blockbuster potential in Longboard’s epilepsy med, brain disease-focused pharma Lundbeck is scooping up the biotech for $2.5 billion.
James Waldron Oct 14, 2024 8:30am
math equations chalkboard multiplication chalk multiply

Longboard’s shares triple as epilepsy med halves seizure rates

Jan 2, 2024 10:49am